N deg - 1 Characteristics of neurons u Cytoskeletal organization u Microtubules and motors u Neuronal intermediate filaments u Neurofilaments u Peripherin,

Slides:



Advertisements
Similar presentations
ALS Research Update 2008 Richard A. Lewis MD Director, Hiller ALS Clinic and Research Center Wayne State University School of Medicine Detroit, Michigan.
Advertisements

Demyelinating Diseases. Demyelination is a common degenerative change in the nervous system secondary to neuronal or axonal injury, But in the group of.
Zinc-deficient SOD in ALS Emily Clark Dr. Joe Beckman Department of Biochemistry/Biophysics.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Control of movement Four subsystems: Lower motor system- Grey matter of spinal cord and brainstem-contain lower motor neurons and lower circuit neurons-the.
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Cellular Degeneration and Ageing Susan Rutherford and Sarah Christie.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
Wellness and Illness. Cell Pathology Cell Pathology –understanding dysfunction of the body’s heirarchy dysfunction –studied at the microscope level 1)
Chapter 8c Neurons: Cellular and Network Properties.
Degenerative Diseases of Brain. Degenerative Diseases Spontaneous, progressive degeneration of neurons Sporadic, Familial Overlapping features.
Microtubules (17) Dynamic instability –Growing and shrinking microtubules can coexist in the same region of a cell. –A given microtubule can switch back.
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
THE NERVOUS SYSTEM. Brain WHAT PARTS DO YOU KNOW THAT ARE IN THE NERVOUS SYSTEM? Spinal Cord Peripheral Nerves.
Amyotrophic Lateral Sclerosis and Superoxide Dimutase 1 (SOD1) Iasson Yi CHEM 4700.
Fondazione IRCCS – Istituto Neurologico “Carlo Besta” Milano Gerstmann-Sträussler-Scheinker disease Fabrizio Tagliavini.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
How does an axon grow? Compare the processes of axonal regeneration in peripheral and central nervous system.
© TND 2005 Oxidative Stress and Inflammation in Neurodegenerative Diseases George Perry and Mark A. Smith Case Western Reserve University Cleveland, Ohio.
Brain Development Lecture 7 PSY391S John Yeomans.
CYTOSKELETON (II) Intermediate filaments and microtubules.
Neurological Disorders
Epidemiology of Alzheimer’s Disease
The Nervous System. iction/drugs/mouse.html.
The organization of the nervous system. Structure of the human cerebral cortex.
Under the supervision of miklós jászberényi
Amyotrophic Lateral Sclerosis
Brain injuries. Concussion Slight brain injury Slight brain injury NO permanent damage NO permanent damage Symptoms: Symptoms: Dizziness Dizziness “seeing.
Cytology Nikon ©.
Pathogenesis and pathology of parkinsonism
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Nervous System. Responds to stimuli to maintain homeostasis. Stimulus (Stimuli) = a signal to which an organism reacts Response = some action or movement.
Path: Nongenetic Degenerative Disorders Chris Pierson, MD, PhD Neuropathologist, Nationwide Children’s Hospital Associate Professor of Pathology
This is an umbrella term, not a disease in its own right. It is a term used for a large group of symptoms that adversely affect the brain and can be caused.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Alzheimer Disease (Senile Dementia) Characterized by progressive memory loss, is increasingly common in developed countries as populations include more.
Nerve Cell Regeneration. NERVE CELL: The function of a neuron is to communicate information. Nerve cells control sensations in the body and other functions.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
CNS Disorders and The Dementias
Title: Alzheimer’s disease and the social
ONTOGENETIC DEVELOPMENT OF THE NERVOUS SYSTEM
Amyotrophic Lateral Sclerosis (ALS)
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Nervous system development and reaction to injury. A
A potential therapy for ALS
Long Term Effects of Concussions
65 year-old female with Alzheimer’s disease
Ch. 7: Neurons: Matter of the Mind Ch. 8: The Nervous System
Ms. Scribner’s Biology class
Nat. Rev. Neurol. doi: /nrneurol
Neuronal Growth and Death: Order and Disorder in the Axoplasm
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
How does an axon grow? Compare the processes of axonal regeneration in peripheral and central nervous system. Dr Sanjay Manohar University of Oxford
Katerina Akassoglou, Wei-Ming Yu, Pinar Akpinar, Sidney Strickland 
Nat. Rev. Urol. doi: /nrurol
Mechanisms Underlying Inflammation in Neurodegeneration
Volume 18, Issue 2, Pages (February 1997)
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Presentation transcript:

N deg - 1 Characteristics of neurons u Cytoskeletal organization u Microtubules and motors u Neuronal intermediate filaments u Neurofilaments u Peripherin, Nestin u Microfilaments u Actins u Axonal transport u Fast transport u Slow transport

N deg - 2

3

4 Neurofilaments (EM)

N deg - 5 Neurofilaments (EM)

N deg - 6 Neurofilaments (biochemistry)

N deg - 7 Neurofilaments u Functions u Maintenance of the axonal organization u Radial growth u Mechanisms u Phosphorylation u Glycosylation?

N deg - 8 Axonal growth u Longitudinal growth u To establish the connection with targets u Growth cone u Early phase of Regeneration/Development u Actin and microtubules u Radial growth u To increase axonal caliber u Late phase of Regeneration/Development u Neurofilaments

N deg - 9 Neurofilaments and Axonal caliber u Inherent neuronal characteristics u Large targets with large axons u Developmental stage u Smaller caliber, less NF u Somatofugal axonal atrophy u Atrophy of the axons in the proximal stump after nerve injury u Related to NF synthesis, transport and phosphorylation

N deg - 10 Neurofilaments and Axonal caliber (Experimental evidence) u Correlation between caliber and NF number u Development u Degeneration/Regeneration u Genetics u Transgenic mice to delete NFs u Spontaneous mutant: Japanese quail

N deg - 11

N deg - 12

N deg - 13 NF: Spontaneous mutant u Mutant Japanese quail u Lack of neurofilaments in axons; small axonal caliber u Growth normally, with some unsteadiness u Still susceptible to acrylamide: a model of neurofilamentous pathology u Mechanism: mutation in NF-L with a premature stop codon

N deg - 14 Transgenic mice with no NF u Absence of NFs due to deletion of NF-L gene u Small caliber with absence of NFs u Grow normally with neuronal swelling in spinal cords and axonal degeneration

N deg - 15 Transgenic mice with no NF

N deg - 16

N deg - 17

N deg - 18

N deg - 19 Neuronal swelling in NF transgenics u Over-expression of NFs u NF-H, NF-M, NF-L (ref) u Mutant or normal NFs u Pathology u Neuronal aggregates of NFs leading to neurodegeneration u Axonal atrophy and degeneration

N deg - 20

N deg - 21 Filamentous neuropathology u NF pathology u Neuronal u Early stage of ALS u Transgenics: NF, SOD u Axonal u Proximal: IDPN u Distal: 2,5-HD u Consequence: Neuronal death (Neurodegeneration)

N deg - 22 Filamentous pathology in neuronal cell bodies

N deg - 23

N deg - 24

N deg - 25 Filamentous pathology in proximal axons

N deg - 26

N deg - 27

N deg - 28 Wallerian degeneration u In the stump distal to the site of nerve injury u Degeneration of axons u Disintegration of axonal cytoskeleton and organization u Proliferation of Schwann cells u Infiltration of macrophages

N deg - 29 Neuronal response in Wallerian degeneration u Chromatolysis u Alteration in the patterns of mRNA u Somatofugal atrophy u Neuronal death in some situations

N deg - 30

N deg - 31 Neurodegenerative diseases u Cortex u Alzheimer disease u Frontotemporal dementia u Motor and coordination system u Motor neuron disease, Amyotrophic lateral sclerosis (ALS) u Parkinson’s disease u Spinocerebellar atrophy (SCA) u Autonomic system u Multiple system atrophy

N deg - 32 Filamentous neuropathology u MT pathology u Acrylamide u NF pathology u Neuronal u Early stage of ALS u Transgenics: NF, SOD u Axonal u Proximal: IDPN u Distal: 2,5-HD u Tau pathology u NFT in Alzheimer disease

N deg - 33 Alzheimer disease u Progressive dementia, particularly over age 65 u Basal foregbrain cholinergic hypothesis u Pathological hallmarks u Senile plaque u Neurofibrillary tangle

N deg - 34 Regenerative strategy for neurodegenerative diseases u Supplement of deficiency: cholinergic medications u Replacement of cells: stem cells, adrenergic cells u Establishment of connections: repulsive and attractive molecules

N deg - 35 神經再生 神經突起的再生 生長錐 (growth cones) 相吸物質 (attractants) 相斥物質 (repulsants)

N deg - 36 神經再生